{"id":"doi:10.1038/s41571-018-0142-8","kind":"review","title":"Cancer immunoediting and resistance to T cell-based immunotherapy","authors":["Jake S. O’Donnell","Michele W.L. Teng","Mark John Smyth"],"author_count":3,"year":2018,"published":"2018-12-06","venue":"Nature Reviews Clinical Oncology","cited_by":1770,"doi":"10.1038/s41571-018-0142-8","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41571-018-0142-8","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41571-018-0142-8","updated":null,"pmid":"30523282","pmcid":null,"openalex_id":"W2902185751","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Cancer Immunotherapy and Biomarkers"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cancer-immunotherapy","name":"Cancer Immunotherapy","domain_slug":"medicine"}],"cited_in_dossiers":[]}